Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      Homepharmaceutical

      pharmaceutical

      Seelos Therapeutics to Participate in Two Upcoming Psychedelic Conferences
      Other

      Seelos Therapeutics to Participate in Two Upcoming Psychedelic Conferences

      August 30, 2022
      Moderna vs. Pfizer, Which COVID Booster Stock Is Better?
      Trading Tips

      Moderna vs. Pfizer, Which COVID Booster Stock Is Better?

      August 29, 2022
      Bristol-Myers Slumps 5% Largest Drop In 2 Years Following Mid-Stage Data for Blood Thinner
      Investing News

      Bristol-Myers Slumps 5% Largest Drop In 2 Years Following Mid-Stage Data for Blood Thinner

      August 29, 2022
      Moderna Sues Pfizer And BioNTech Over mRNA Patent Infringement
      Investing News

      Moderna Sues Pfizer And BioNTech Over mRNA Patent Infringement

      August 29, 2022
      Omicron-Based Booster: Pfizer and BioNTech Seeking EU Approval
      Investing News

      Omicron-Based Booster: Pfizer and BioNTech Seeking EU Approval

      August 29, 2022
      Should Pfizer Shareholders be Concerned About Declining Demand for COVID-19 Vaccine?
      Trading Tips

      Should Pfizer Shareholders be Concerned About Declining Demand for COVID-19 Vaccine?

      August 26, 2022
      Battle for mRNA technology, Moderna sues Pfizer and BioNTech for patent infringement
      Investing News

      Battle for mRNA technology, Moderna sues Pfizer and BioNTech for patent infringement

      August 26, 2022
      Japan Approves AstraZeneca’s Request to Widen Use of 3 Drugs
      Investing News

      Japan Approves AstraZeneca’s Request to Widen Use of 3 Drugs

      August 25, 2022
      The EC has approved J&J’s Tecvayli for the treatment of multiple myeloma.
      Investing News

      The EC has approved J&J’s Tecvayli for the treatment of multiple myeloma.

      August 25, 2022
      Annovis Bio’s Phase III Dosing Begins for Parkinson’s Study
      Investing News

      Annovis Bio’s Phase III Dosing Begins for Parkinson’s Study

      August 25, 2022
      « 1 … 13 14 15 16 17 … 19 »

       

      LATEST NEWS

      • Investing News Ulta Beauty’s Q3 2025 Earnings Highlight Growth
      • Investing News Beta Technologies Q3 IPO Insights
      • Investing News Salesforce Reports Robust Q3 2026 Earnings
      • Investing News Salesforce’s Stock Boost Amid Raised Guidance
      • Investing News Macy’s Q3 2025 Earnings Overview

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025